Seven Fleet Capital Management LP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 2092021
MOUNTAIN VIEW, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,586,443
+$1,804,590 QoQ
Shares Held
128,487
+165.4% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#60
of 182 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Seven Fleet Capital Management LP holds $164,514,544 across 90 Biotechnology names. KALV ranks #24 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TNGX |
Tango Therapeutics, Inc.
|
502,012 | $10,502,091 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
80,792 | $7,857,022 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
195,685 | $7,494,735 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
209,547 | $7,088,975 | |
| 5 | IPSC |
Century Therapeutics, Inc.
|
2,947,826 | $6,662,086 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
164,030 | $6,429,976 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
108,450 | $6,302,029 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
149,399 | $5,750,367 |
All Filings in KALV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,586,443 | 128,487 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $781,853 | 48,412 | Shares | Sole | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||